Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 11:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 3,083 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Surgical Management Clear all

Conditions: Thoracic Surgery, Cardiopulmonary Bypass
Interventions: blood pressure maintenance based on cerebral blood flow autoregulation measurement, Control group; Drug · Device
Lead sponsor: Northwestern University; Other
Eligibility: 55 Years and older
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreas Cancer, Biliary Tract Cancer
Interventions: Alcohol Injection, Placebo Injection; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cardiac Surgery
Interventions: Sucrosomial Iron (SI); Dietary Supplement
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Morbid Obesity, Cardiovascular Disease, Fatty Acid Levels
Interventions: Bariatric Surgery; Procedure
Lead sponsor: University of Cincinnati; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Fibroids, Uterine
Interventions: hysterectomy, Uterine arterial embolization, myomectomy, Medical Therapy, endometrial ablation, magnetic resonance guided focused ultrasound, radiofrequency ablation; Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 3,094 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 9
States / cities: San Francisco, California • Bethesda, Maryland • Boston, Massachusetts + 6 more

Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7
Interventions: Computed Tomography, Magnetic Resonance Imaging, Pazopanib Hydrochloride, Placebo Administration, Questionnaire Administration; Procedure · Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2027
U.S. locations: 579
States / cities: Fairbanks, Alaska • Tucson, Arizona • Hot Springs, Arkansas + 355 more

Conditions: Breast Cancer Prevention, Mammographic Density
Interventions: Ultrasound-guided core needle biopsy, Denosumab, Blood draw, Calcium, Vitamin D; Procedure · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 35 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: HLHS
Interventions: Longeveron Mesenchymal Stem Cells; Biological
Lead sponsor: Longeveron Inc.; Industry
Eligibility: 1 Day to 1 Year
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 5
States / cities: Atlanta, Georgia • Baltimore, Maryland • Cincinnati, Ohio + 1 more

Conditions: Post-Operative Pain
Interventions: LMX4, LMX4 Placebo; Drug
Lead sponsor: Ferndale Laboratories, Inc.; Industry
Eligibility: 3 Months to 3 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma
Interventions: Cytoreductive Surgery (CRS), Adjuvant Chemotherapy, Questionnaire, Hyperthermic intraperitoneal chemotherapy, Carboplatin, Paclitaxel, Cisplatin; Procedure · Drug · Other
Lead sponsor: Mercy Medical Center; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Head and Neck Cancer
Interventions: Anti-OX40 antibody administration, Surgical Resection; Drug · Procedure
Lead sponsor: Providence Health & Services; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Hypotension During Surgery, Hypotension Postprocedural
Interventions: Surgery with Active MAP Management, Surgery without Active MAP Management; Device · Other
Lead sponsor: Jennie E Minnich; Other
Eligibility: 30 Days to 30 Days
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pediatric Disorder
Interventions: Acetaminophen, Ibuprofen; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 3 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Liver Transplant Surgery
Interventions: Intercept Fibrinogen Complex (IFC), Cryoprecipitate Antihemophilic Factor (AHF); Biological
Lead sponsor: Trauma Hemostatis and Oxygenation Research (THOR) Network; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Biliary Tract Cancer
Interventions: becatecarin, 5-Fluorouracil Plus Leucovorin; Drug
Lead sponsor: Helsinn Healthcare SA; Industry
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 27
States / cities: Birmingham, Alabama • Long Beach, California • Orange, California + 24 more

Conditions: Diabetic Foot Ulcer, Chronic Ulcers of the Lower Limb
Interventions: Biodynamik XT3; Device
Lead sponsor: Biodynamik, Inc; Industry
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Head and Neck Surgery
Interventions: REVEAL 475 System, Bevonescein; Device · Drug
Lead sponsor: Alume Biosciences, Inc.; Industry
Eligibility: 16 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Lung Volume Reduction Surgery
Interventions: Propofol, Desflurane; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: New York, New York

Conditions: Airway Complication of Anesthesia
Interventions: Advanced airway management; Procedure
Lead sponsor: University of Turin, Italy; Other
Eligibility: 18 Years and older
Enrollment: 10,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Dallas, Texas • Houston, Texas

Conditions: Meniscus Tear, Meniscus; Derangement, Meniscus Lesion, Meniscus Disorder
Interventions: Fisetin, Placebo oral capsule; Drug
Lead sponsor: Austin V Stone; Other
Eligibility: 18 Years to 45 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Resectable Pancreatic Cancers
Interventions: Gemcitabine/nab-Paclitaxel, Radiation therapy, Sugical resection, Adjuvant chemotheapy; Drug · Radiation · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Critical Limb Ischemia, Malnutrition, Nutritional Supplements
Interventions: Ensure Surgery Immunonutrition Shake, Ensure Enlive Advanced Nutrition Shake; Drug
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Trauma Injury, Bone Infection
Interventions: imaging 24 hours following intravenous administration of ICG; Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Phantom Limb Pain, Postoperative Pain, Neuroma, Acute Pain, Chronic Pain, Residual Limbs, Amputation
Interventions: Peripheral nerve stimulation, Standard Medical Therapy; Device · Other
Lead sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Cerebral Autoregulation Monitoring During Cardiac Surgery

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control

Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery

Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment

Patient Centered Results for Uterine Fibroids

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

RANKL Inhibition and Breast Tissue Biomarkers

Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery

HOT: HIPEC in Ovarian Cancer as Initial Treatment

Anti-OX40 Antibody in Head and Neck Cancer Patients

Brain Autoregulation Research Study

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

Fibrinogen in Liver Transplant

XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors

Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds

Feasibility and Efficacy Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery

Effects of Desflurane and Propofol During Lung Volume Reduction Surgery

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair

Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer

Nutrition in Patient With Critical Limb Ischemia

ICG 24h Prior to Operative Treatment of Orthopaedic Infection

Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain